NORML

JANUARY 31, 2019

“These men and women put on the uniform to defend this nation’s freedoms and it is the height of hypocrisy for the federal government to deny them rights afforded to the millions of other Americans who reside in states where access to medical cannabis is legally recognized.”

Clinical Trials 195

Clinical Trials Chronic Pain Data Treatment 195

Veriheal

MARCH 2, 2024

In December of 2023, the country recently made a new move towards reform that could stimulate the cannabidiol (CBD) industry and provide many patients, such as those with epilepsy , with access to potentially life-changing medical treatments. and Europe to treat severe epilepsy, as well as other medical conditions.

Legalization 105

Legalization Epilepsy Clinical Trials THC 105

Veriheal

MARCH 20, 2023

While decriminalization decreases the negative impact of legal issues, it does not provide accessible, safe, and regulated psilocybin for those seeking treatment. Andy Smith (D) stated that he is “working on a bill forming a psychedelic medicine task force so Minnesotans can access these life-affirming treatments. Missouri Rep.

Clinical Trials 98

Clinical Trials Therapy Decriminalization Treatment 98

Veriheal

JUNE 30, 2023

For their analysis, researchers conducted qualitative interviews with 13 individuals who had participated in a psilocybin clinical trial. The 13 individuals were chosen because of their reported improvements in negative drinking behavior following the clinical trial.

Clinical Trials 98

Clinical Trials Research and Development Therapy Policy 98

MMJ Recs

MAY 9, 2024

As such, we provide you with a comprehensive guide for veterans using medical cannabis and the various aspects of it, including its usage, accessibility, legal considerations, healthcare options, and available resources. Navigating the complexities surrounding the Veterans Administration and medical cannabis can be daunting.

Research and Development 52

Research and Development Therapy Clinical Trials Treatment 52

Cannabis Law Report

JUNE 24, 2022

The legislation from Senate President Nicholas Scutari (D), who has long championed cannabis reform in the Garden State, would further create a system of licensed businesses to provide psilocybin services in supervised settings. Full story at.

Clinical Trials 52

Clinical Trials Legalization Research and Development Therapy 52

Cannabis Law Report

MAY 31, 2022

The only psychedelic drug that is approved (outside of clinical trials) for psychiatric use—as opposed to anesthesia—through the traditional medical system is Ketamine. 2022 Active FDA Clinical Trials and State-Regulated Systems. Active FDA Regulated Clinical Trials*. On March 5, 2019, the U.S. Schedule I.

Clinical Trials 52

Clinical Trials Legalization Therapy Decriminalization 52

Canna Law Blog

NOVEMBER 10, 2020

We discussed how licensed facilities won’t be up and running for a few more years, and how, in the meantime, people will have to make do with general decriminalization under Measure 109 and maybe, in certain cases, reliance on Right to Try access. It’s quite restrictive. Or, it could be because FDA is sort of a drag about everything.

Therapy 80

Therapy Clinical Trials Decriminalization Patients 80

MMJ Recs

DECEMBER 17, 2023

Enacted in 2015, the program was designed to provide a narrow avenue for patients suffering from qualifying conditions to access low-THC cannabis under the supervision of qualified healthcare professionals. there may be increased momentum for legislative changes in Texas.

Law 52

Law Dispensary Clinical Trials Programs 52

Canna Law Blog

NOVEMBER 27, 2021

In fact, Small Pharma has been conducting trials as reported by the BBC and expanded its clinical trial this past summer. regulators to launch a clinical program to study the use of DMT for the treatment of stroke-related dysfunction. Psychedelics Legislation Advances in California.

Therapy 89

Therapy Clinical Trials DEA Microdosing 89

Cannabis Law Report

APRIL 21, 2022

Commercialization & Patient Access · Any City, Any State, California. It has been designated a Breakthrough Therapy by the FDA and the results of our pivotal Phase 3 clinical trial were published in Nature Medicine and profiled on the front page of The New York Times. About MAPS Public Benefit Corporation (MAPS PBC).

Advocacy 52

Advocacy Therapy Clinical Trials Environment 52

Cannabis Law Report

NOVEMBER 7, 2021

The committee has been formed to expand the company’s pharmaceutical expertise and accelerate R&D, product development and clinical trials ahead of a potential NASDAQ listing. The committee will also enable CPH to accelerate R&D, product development and other clinical trials ahead of its potential NASDAQ listing.

Medicine 52

Medicine Clinical Trials Research and Development Pharmaceutical 52

Cannabis Law Report

JULY 24, 2021

The groundbreaking progress that we’ve seen from the Multidisciplinary Association for Psychedelic Studies (MAPS) in its Phase 3 clinical trials of MDMA-assisted psychotherapy for Post-Traumatic Stress Disorder (PTSD), including receiving Breakthrough Therapy Designation from the Food and Drug Administration (FDA), shows great promise to date.

Research and Development 105

Research and Development Clinical Trials Therapy Events 105

Veriheal

MAY 26, 2022

RoC also works to increase patients’ access to medical cannabis by helping U.S. states pass relevant legislation and educating doctors about the power of cannabis medicine. To date, Veriheal’s global team has helped hundreds of thousands of patients gain access to medical cannabis.

Advocacy 98

Advocacy Patients Clinical Trials Education 98

Veriheal

MARCH 23, 2023

The people of Japan, a country renowned for its sushi cuisine scene, iconic Mount Fuji, and eye-catching cherry blossom trees, may soon have access to legal medicinal marijuana for intractable diseases. On Tuesday, January 24, several legislative bills were unveiled by the Japanese government.

Legalization 66

Legalization Marijuana Clinical Trials Seed-To-Sale 66

Cannabis Law Report

JULY 1, 2021

Clinical trials repeatedly demonstrate their promise for treating mood, anxiety, and substance use disorders. At least eight other states are considering similar legislation to legalize or decriminalize psychedelics. Access to Psychedelic Therapies and Equity in Emerging Psychedelics Industries. Background.

Law 59

Law Policy Research and Development Clinical Trials 59

SpeedWeed

JULY 6, 2021

By analyzing social, legal, and political barriers to access in this context, we hope to advance the understanding of their potential impact as therapeutics.”. The project also intends to advance research into how psychedelics can heal trauma and how to ensure equitable access to these therapies.

Policy 52

Policy Law Research and Development Therapy 52

Cannabis Law Report

NOVEMBER 29, 2019

Different legislation across EU countries on prescribing cannabis-based medicines can hinder patients’ access to their treatment when they travel abroad, EUMCA said. Lack of clinical trials is a major reason why doctors are cautious about the drug. German model.

Medicine 59

Medicine Clinical Trials Treatment Access 59

Cannabis Law Report

FEBRUARY 10, 2022

Oregon isn’t alone; legislators in New York and Washington State also recently introduced bills to legalize supervised psilocybin services in those states. Congress passed the RTT Act in 2018 to give qualifying patients access to investigational drugs outside of a clinical trial setting. Enter the Right to Try (RTT) Act.

DEA 52

DEA Clinical Trials Policy Research and Development 52

Canna Law Blog

OCTOBER 8, 2020

For one, research on the benefits of psilocybin therapy in treating depression is farther along than most people think; the results are quite promising ; and more clinical trials are underway, including at esteemed research institutions like Johns Hopkins. See also: FDA Approves Drug Trial for Psilocybin (Magic Mushrooms).

Research and Development 54

Research and Development Decriminalization Clinical Trials Therapy 54

Cannabis Law Report

JULY 9, 2021

Then, in November 2019, the FDA granted the designation to the nonprofit Usona Institute to study psilocybin’s effect on major depressive order, for which clinical trials are currently under way. See Usona Institute, A Study of Psilocybin for Major Depressive Disorder (MDD) , Clinical Trial ID NCT03866174, available at [link].

Law 105

Law Therapy Clinical Trials Research and Development 105

CannaMD

NOVEMBER 6, 2019

The authors report that the legalization of medical marijuana: May be effective at reducing opioid reliance as survey respondents living in states with medical cannabis legislation are much less apt to report using opioid analgesics than people living in states without such laws, net other factors. Opioid Prescriptions Likely to Decline.

Marijuana 87

Marijuana Patients Clinical Trials Data 87

MMJ Recs

DECEMBER 22, 2023

This shift can be attributed to increased access to information, a more liberal societal outlook, and a willingness to explore alternative healthcare options. Positive depictions of individuals benefiting from cannabis-based treatments, as well as coverage of legislative developments, have humanized the issue.

Marijuana 52

Marijuana Chronic Pain Advocacy Research and Development 52

TheAnswerPage

JANUARY 11, 2022

In most cases, state medical marijuana legislation was passed without input from individual medical professionals or the medical community. As more states loosen their legislation surrounding marijuana use, health-care providers are increasingly expected to advise patients regarding its potential health benefits and safe use.

Patients 98

Patients Education Marijuana Therapy 98

Cannabis Law Report

JUNE 9, 2022

The bill would expand patients’ access to the necessary treatment for more than 50 conditions, including cancer and post-traumatic stress disorder (PTSD), neurological diseases, and chronic pain of neuropathic origin. Draft Law of Ukraine. ARV (revised). REFERENCE to the EU acquis. explanatory note. Comparative table. LAW OF UKRAINE.

Seed-To-Sale 52

Seed-To-Sale Legalization Cultivation Medicine 52

The Cannigma

JULY 1, 2022

The highest quality form of scientific research, in terms of whether the results provide predictive power (which is what science is all about), is the placebo controlled, double blind, randomized clinical trial. Non-clinical research can help answer questions regarding safety and risk in very powerful ways.

Research and Development 108

Research and Development Data THC Clinical Trials 108

Cannabis Law Report

APRIL 10, 2019

MP Philippa Whitford (representing Central Ayrshire ), a doctor, called for more support for clinical trials so that doctors will be more willing to prescribe medical cannabis products: “That is quite scary for doctors, particularly as if it is an unlicensed drug, they have to sign a form to say that they accept personal liability.

Clinical Trials 51

Clinical Trials Epilepsy Medicine Research and Development 51

Cannabis Law Report

MARCH 1, 2019

Natalie has worked with private hospitals and clinics in relation to medical malpractice claims, and assisted on cases involving medical devices product liability and clinical trials. Acting on a broad range of cases, all with a medical or injury element, usually on the instructions of insurers.

Medicine 45

Medicine Clinical Trials Patients Treatment 45

Cannabis Law Report

DECEMBER 14, 2019

At the local level, Bell and Smith said the rise in patient approvals could be attributed to legislation put in place in New South Wales that loosened the requirements for prescribing medical marijuana. There’s also EcoFibre (ASX: EOF ), which boasts a market capitalisation of AU$1 billion.

Pharmaceutical 98

Pharmaceutical Patients Clinical Trials Hemp 98

Cannabis Info

OCTOBER 11, 2019

There are 79 coffee shops inside these areas, all of that are required by legislation to modify over to authorized provide from their beforehand authorized sources up to now. These are: Almere, Arnhem, Breda, Groningen, Heerlen, Hellevoetsluis, Masstricht, Nijmegen, Tilburg, and Zaanstad.

Business 45

Business Epilepsy Clinical Trials Treatment 45

Cannabis Law Report

OCTOBER 15, 2021

Solutech™ is one of the fastest-acting, most bioavailable and comprehensively studied delivery systems for cannabinoids, including THC and CBD, uniquely differentiated for relative oral bioavailability and absorption by a Phase I human clinical trial.

Seed-To-Sale 52

Seed-To-Sale Cultivation Clinical Trials Cannabinoids 52

Canna Law Blog

NOVEMBER 6, 2021

Despite overwhelming evidence that psilocybin is misclassified, this barrier restricts research, stifles competition and innovation, and inhibits access. But only if it is made affordable and accessible. Instead, qualifying evidence may come from adequate and well-controlled clinical trials. The first is legislative.

Clinical Trials 98

Clinical Trials DEA Research and Development Therapy 98

Veriheal

JUNE 29, 2021

In order to legally access other therapies including nature-based options such as psilocybin , you must gain access under a Right to Try law which requires you to have a terminal condition. The FDA refers to this program as the expanded access program on their website. A Push by Patients. Patients Are Not In This Alone.

Therapy 55

Therapy DEA Patients Clinical Trials 55

Cannabis Law Report

OCTOBER 26, 2019

One such circumstance is a clinical trial. A clinical trial in Australia must have an Australian sponsor (whether it be an individual (e.g., Two of the avenues for supply of UTGs for clinical trials are the Clinical Trial Exemption (CTX) Scheme and the Clinical Trial Notification (CTN) Scheme.

Clinical Trials 45

Clinical Trials Medicine Research and Development Compliance 45

Veriheal

DECEMBER 21, 2022

This makes history by enacting the first piece of standalone federal cannabis reform legislation in U.S. While both options seem better than the current situation, they could actually make it more difficult to access. Each legislative session, advocates have their fingers crossed that their most recently drafted bill will advance.

Clinical Trials 98

Clinical Trials Marijuana Decriminalization History 98

Cannabis Law Report

JULY 25, 2022

Reporter Elise Worthington also investigates the dark side of this form of therapy where disturbing cases of abuse and malpractice are emerging in both clinical trials and the underground. The charity was eventually instructed to pull an advertisement for the study by the ethics committee that conditionally approved the trial.

Medicine 52

Medicine Therapy Research and Development Business 52

CannaTech

SEPTEMBER 23, 2019

The acceptance of medical cannabis by clinicians, researchers and government bodies is fairly universal, and patients have benefited from widespread access to full-spectrum cannabis in flower and oil form. Israel’s approach to cannabis has contributed to reducing stigma and increasing access for patients around the world.

Patients 79

Patients Policy Clinical Trials Research and Development 79